Avery W. Catlin

2008

In 2008, Avery W. Catlin earned a total compensation of $1.1M as Senior Vice President and Chief Financial Officer at Celldex Therapeutics, a 262% increase compared to previous year.

Compensation breakdown

Bonus$57,700
Option Awards$762,665
Salary$262,170
Stock Awards$50,000
Other$3,483
Total$1,136,018

Catlin received $762.7K in option awards, accounting for 67% of the total pay in 2008.

Catlin also received $57.7K in bonus, $262.2K in salary, $50K in stock awards and $3.5K in other compensation.

Rankings

In 2008, Avery W. Catlin's compensation ranked 3,976th out of 9,135 executives tracked by ExecPay. In other words, Catlin earned more than 56.5% of executives.

ClassificationRankingPercentile
All
3,976
out of 9,135
57th
Division
Manufacturing
1,424
out of 3,436
59th
Major group
Chemicals And Allied Products
272
out of 815
67th
Industry group
Drugs
161
out of 597
73rd
Industry
In Vitro and In Vivo Diagnostic Substances
9
out of 51
82nd
Source: SEC filing on April 26, 2011.

Catlin's colleagues

We found five more compensation records of executives who worked with Avery W. Catlin at Celldex Therapeutics in 2008.

2008

Una Ryan

Celldex Therapeutics

Chief Executive Officer

2008

Anthony Marucci

Celldex Therapeutics

Chief Executive Officer

2008

Tibor Keler

Celldex Therapeutics

Chief Scientific Officer

2008

Thomas Davis

Celldex Therapeutics

Chief Medical Officer

2008

Ronald Newbold

Celldex Therapeutics

Senior Vice President, Business Development

In-depth

You may also like